<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39359793</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2049-0801</ISSN><JournalIssue CitedMedium="Print"><Volume>86</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Annals of medicine and surgery (2012)</Title><ISOAbbreviation>Ann Med Surg (Lond)</ISOAbbreviation></Journal><ArticleTitle>Efficacy of vitamin D supplementation in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>6079</StartPage><EndPage>6090</EndPage><MedlinePgn>6079-6090</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MS9.0000000000002445</ELocationID><Abstract><AbstractText Label="CONTEXT" NlmCategory="UNASSIGNED">COVID-19 has substantial effects on respiratory health and overall well-being. Recent studies suggest vitamin D as a potential treatment, but the results are inconclusive.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The authors conducted a systematic review of randomized controlled trials (RCTs) to examine the link between vitamin D and patients with COVID-19.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="UNASSIGNED">The authors searched electronic databases PubMed, Cochrane, CINAHL, EMBASE and Google Scholar from their inception till August 2023.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="UNASSIGNED">Inclusion criteria used in our systematic review include: (1) patients who tested positive for COVID-19, (2) intervention was vitamin D supplementation, (3) the comparator was either a placebo, standard care of treatment, or, no treatment, (4) at least one of the clinical outcomes of interest were investigated, (5) study design being RCTs.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="UNASSIGNED">Two independent reviewers manually extracted information from selected articles, including study characteristics, patient characteristics, and the primary outcomes: all-cause mortality, ICU and hospital stay length and secondary outcomes: mechanical ventilation, supplemental oxygen, ICU admission, and adverse events. Risk ratios or mean differences and 95% CIs were calculated using a random-effects model.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="UNASSIGNED">The authors' analysis included 14 RCTs with 2165 patients. Vitamin D significantly reduced ICU admissions and lowered the need for mechanical ventilation compared to placebo. However, it did not significantly affect hospital stay length, ICU stay length, mechanical ventilation duration, mortality, or the need for supplemental oxygen.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Vitamin D does not significantly improve certain clinical outcomes, such as hospital and ICU stay length, for patients with COVID-19. However, it still may be significantly beneficial in decreasing the burden on intensive care services.</AbstractText><CopyrightInformation>Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adil</LastName><ForeName>Mariam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Dow University of Health Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saleem</LastName><ForeName>Muhammad Meeran</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0003-4122-6770</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Dow University of Health Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vijay</LastName><ForeName>Sneha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Dow University of Health Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehsan</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, King Edward Medical University, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atiq</LastName><ForeName>Isha</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine, Dow University of Health Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anwar</LastName><ForeName>Eman</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Aga Khan University, Karachi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oduoye</LastName><ForeName>Malik Olatunde</ForeName><Initials>MO</Initials><Identifier Source="ORCID">0000-0001-9635-9891</Identifier><AffiliationInfo><Affiliation>The Medical Research Circle, Bukavu, Democratic Republic of Congo.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med Surg (Lond)</MedlineTA><NlmUniqueID>101616869</NlmUniqueID><ISSNLinking>2049-0801</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">calcitriol</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">randomized controlled trials</Keyword><Keyword MajorTopicYN="N">vitamin D</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>4</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39359793</ArticleId><ArticleId IdType="pmc">PMC11444563</ArticleId><ArticleId IdType="doi">10.1097/MS9.0000000000002445</ArticleId><ArticleId IdType="pii">AMSU-D-24-00500</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . Coronavirus Disease (COVID-19) Pandemic. World Health Organization; 2020.</Citation></Reference><Reference><Citation>Gao Y, Ding M, Dong X, et al. . Risk factors for severe and critically ill COVID-19 patients: a review. Allergy 2021;76:428–455.</Citation><ArticleIdList><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Guo H, Zhou P, et al. . Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2021;19:141–154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.worldometers.info/coronavirus/ Worldometer. Accessed 4 Sept 2023.</Citation></Reference><Reference><Citation>Khundmiri SJ, Murray RD, Lederer E. PTH and vitamin D. Comprehens Physiol, 6:561–601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11163478</ArticleId><ArticleId IdType="pubmed">27065162</ArticleId></ArticleIdList></Reference><Reference><Citation>Greiller C, Martineau A. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients, 7:4240–4270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4488782</ArticleId><ArticleId IdType="pubmed">26035247</ArticleId></ArticleIdList></Reference><Reference><Citation>Bui L, Zhu Z, Hawkins S, et al. . Vitamin D regulation of the immune system and its implications for COVID-19: a mini-review. SAGE Open Med 2021;9:20503121211014073.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135207</ArticleId><ArticleId IdType="pubmed">34046177</ArticleId></ArticleIdList></Reference><Reference><Citation>Amrein K, Scherkl M, Hoffmann M, et al. . Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr 2020;74:1498–1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7091696</ArticleId><ArticleId IdType="pubmed">31959942</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolliffe DA, Camargo CA, Jr, Sluyter JD, et al. . Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol 2021;9:276–292.</Citation><ArticleIdList><ArticleId IdType="pubmed">33798465</ArticleId></ArticleIdList></Reference><Reference><Citation>Meltzer DO, Best TJ, Zhang H, et al. . Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA Netw Open 2020;3:e2019722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489852</ArticleId><ArticleId IdType="pubmed">32880651</ArticleId></ArticleIdList></Reference><Reference><Citation>Orchard L, Baldry M, Nasim-Mohi M, et al. . Vitamin-D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients. Clin Chem Lab Med 2021;59:1155–1163.</Citation><ArticleIdList><ArticleId IdType="pubmed">33554566</ArticleId></ArticleIdList></Reference><Reference><Citation>Bychinin MV, Klypa TV, Mandel IA, et al. . Low circulating vitamin D in intensive care unit-admitted COVID-19 patients as a predictor of negative outcomes. J Nutr 2021;151:2199–2205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8194597</ArticleId><ArticleId IdType="pubmed">33982128</ArticleId></ArticleIdList></Reference><Reference><Citation>Glinsky GV. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells. Biomedicines 2020;8:129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7277789</ArticleId><ArticleId IdType="pubmed">32455629</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek Mahdavi A. A brief review of the interplay between vitamin D and angiotensin-converting enzyme 2: implications for a potential treatment for COVID-19. Rev Med Virol 2020;30:e2119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362103</ArticleId><ArticleId IdType="pubmed">32584474</ArticleId></ArticleIdList></Reference><Reference><Citation>Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, et al. . Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study. J Steroid Biochem Mol Biol 2020;203:105751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7456194</ArticleId><ArticleId IdType="pubmed">32871238</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastogi A, Bhansali A, Khare N, et al. . Short-term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Postgrad Med J 2022;98:87–90.</Citation><ArticleIdList><ArticleId IdType="pubmed">33184146</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabico S, Enani MA, Sheshah E, et al. . Effects of a 2-week 5000 IU versus 1000 IU vitamin D3 supplementation on recovery of symptoms in patients with mild to moderate Covid-19: a randomized clinical trial. Nutrients 2021;13:2170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8308273</ArticleId><ArticleId IdType="pubmed">34202578</ArticleId></ArticleIdList></Reference><Reference><Citation>Annweiler G, Corvaisier M, Gautier J, et al. . Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: The GERIA-COVID Quasi-Experimental Study. Nutrients 2020;12:3377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7693938</ArticleId><ArticleId IdType="pubmed">33147894</ArticleId></ArticleIdList></Reference><Reference><Citation>Murai IH, Fernandes AL, Sales LP, et al. . Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial. JAMA 2021;325:1053–1060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7890452</ArticleId><ArticleId IdType="pubmed">33595634</ArticleId></ArticleIdList></Reference><Reference><Citation>Oristrell J, Oliva JC, Subirana I, et al. . Association of calcitriol supplementation with reduced COVID-19 mortality in patients with chronic kidney disease: a population-based study. Biomedicines 2021;9:509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8147982</ArticleId><ArticleId IdType="pubmed">34063015</ArticleId></ArticleIdList></Reference><Reference><Citation>Velikova T, Fabbri A, Infante M. The role of vitamin D as a potential adjuvant for COVID-19 vaccines. Eur Rev Med Pharmacol Sci 2021;25:5323–5327.</Citation><ArticleIdList><ArticleId IdType="pubmed">34533808</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereda E, Bogliolo L, Lobascio F, et al. . Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy, Italy. Nutrition (Burbank, Los Angeles County, Calif) 2021;82:111055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7657015</ArticleId><ArticleId IdType="pubmed">33288411</ArticleId></ArticleIdList></Reference><Reference><Citation>Varikasuvu SR, Thangappazham B, Vykunta A, et al. . COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials. Expert Rev Anti Infect Ther 2022;20:907–913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8862170</ArticleId><ArticleId IdType="pubmed">35086394</ArticleId></ArticleIdList></Reference><Reference><Citation>Kümmel LS, Krumbein H, Fragkou PC, et al. . Vitamin D supplementation for the treatment of COVID-19: a systematic review and meta-analysis of randomized controlled trials. Front Immunol 2022;13:1023903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9659578</ArticleId><ArticleId IdType="pubmed">36389703</ArticleId></ArticleIdList></Reference><Reference><Citation>Sîrbu AC, Sabin O, Bocsan IC, et al. . The effect of vitamin D supplementation on the length of hospitalisation, intensive care unit admission, and mortality in COVID-19—a systematic review and meta-analysis. Nutrients 2023;15:3470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10421164</ArticleId><ArticleId IdType="pubmed">37571407</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini B, El Abd A, Ducharme FM. Effects of vitamin D supplementation on COVID-19 related outcomes: a systematic review and meta-analysis. Nutrients 2022;14:2134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9147949</ArticleId><ArticleId IdType="pubmed">35631275</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira M, Dantas Damascena A, Galvão Azevedo LM, et al. . Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr 2022;62:1308–1316.</Citation><ArticleIdList><ArticleId IdType="pubmed">33146028</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrelli F, Luciani A, Perego G, et al. . Therapeutic and prognostic role of vitamin D for COVID-19 infection: a systematic review and meta-analysis of 43 observational studies. J Steroid Biochem Mol Biol 2021;211:105883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7997262</ArticleId><ArticleId IdType="pubmed">33775818</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clin Res Ed) 2009;339:b2700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . COVID-19: Case definitions. World Health Organization: WHO. Surveillance_Case_Definition-2022.1. Accessed 4 Sept 2023. https://www.who.int/publications-detail-redirect/WHO-2019-nCoV</Citation></Reference><Reference><Citation>Clarivate Endnote: Reference Management Tool (version 20). Accessed 4 Sept 2023. https://endnote.com/downloads.</Citation></Reference><Reference><Citation>Sterne JAC, Savović J, Page MJ, et al. . RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clin Res Ed) 2019;366:l4898.</Citation><ArticleIdList><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks JJHJ, Altman DG. Chapter 10: Analysing data and undertaking meta-analyses. In Cochrane Handbook for Systematic Reviews of Interventions, version 62. Cochrane; 2021.</Citation></Reference><Reference><Citation>Cannata-Andía JB, Díaz-Sottolano A, Fernández P, et al. . A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial. BMC Med 2022;20:83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8853840</ArticleId><ArticleId IdType="pubmed">35177066</ArticleId></ArticleIdList></Reference><Reference><Citation>Annweiler C, Beaudenon M, Gautier J, et al. . High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): a multicenter, open-label, randomized controlled superiority trial. PLoS Med 2022;19:e1003999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9154122</ArticleId><ArticleId IdType="pubmed">35639792</ArticleId></ArticleIdList></Reference><Reference><Citation>Domazet Bugarin J, Dosenovic S, Ilic D, et al. . Vitamin D supplementation and clinical outcomes in severe COVID-19 patients-randomized controlled trial. Nutrients 2023;15:1234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10005311</ArticleId><ArticleId IdType="pubmed">36904232</ArticleId></ArticleIdList></Reference><Reference><Citation>Bychinin MV, Klypa TV, Mandel IA, et al. . Effect of vitamin D3 supplementation on cellular immunity and inflammatory markers in COVID-19 patients admitted to the ICU. Sci Rep 2022;12:18604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9632570</ArticleId><ArticleId IdType="pubmed">36329227</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamir YM, Amir H, Lim S, et al. . A randomized pilot study using calcitriol in hospitalized COVID-19 patients. Bone 2022;154:116175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8425676</ArticleId><ArticleId IdType="pubmed">34508882</ArticleId></ArticleIdList></Reference><Reference><Citation>Karonova TL, Golovatyuk KA, Kudryavtsev IV, et al. . Effect of cholecalciferol supplementation on the clinical features and inflammatory markers in hospitalized COVID-19 patients: a randomized, open-label, single-center study. Nutrients 2022;14:2602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9268385</ArticleId><ArticleId IdType="pubmed">35807783</ArticleId></ArticleIdList></Reference><Reference><Citation>Maghbooli Z, Sahraian MA, Jamalimoghadamsiahkali S, et al. . Treatment with 25-hydroxyvitamin D3 (calcifediol) is associated with a reduction in the blood neutrophil-to-lymphocyte ratio marker of disease severity in hospitalized patients with COVID-19: a pilot multicenter, randomized, placebo-controlled, double-blinded clinical trial. Endocr Practs 2021;27:1242–1251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8511889</ArticleId><ArticleId IdType="pubmed">34653608</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariani J, Antonietti L, Tajer C, et al. . High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: multicentre randomized controlled clinical trial. PLoS ONE 2022;17:e0267918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9140264</ArticleId><ArticleId IdType="pubmed">35622854</ArticleId></ArticleIdList></Reference><Reference><Citation>De Niet S, Trémège M, Coffiner M, et al. . Positive effects of vitamin D supplementation in patients hospitalized for COVID-19: a randomized, double-blind, placebo-controlled trial. Nutrients 2022;14:3048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9330587</ArticleId><ArticleId IdType="pubmed">35893907</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarhan N, Abou Warda AE, Sarhan RM, et al. . Evidence for the efficacy of a high dose of vitamin D on the hyperinflammation state in moderate-to-severe COVID-19 patients: a randomized clinical trial. Medicina (Kaunas) 2022;58:1358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9609310</ArticleId><ArticleId IdType="pubmed">36295519</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres M, Casado G, Vigón L, et al. . Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with a high dose of vitamin D. Biomed Pharmacother 2022;150:112965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9008199</ArticleId><ArticleId IdType="pubmed">35468580</ArticleId></ArticleIdList></Reference><Reference><Citation>Tentolouris N, Samakidou G, Eleftheriadou I, et al. . The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID-19 patients. A systematic review, meta-analysis and meta-regression. Diabetes Metab Res Rev 2022;38:e3517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9015406</ArticleId><ArticleId IdType="pubmed">34965318</ArticleId></ArticleIdList></Reference><Reference><Citation>Raucci F, Mansour AA, Casillo GM, et al. . Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms. Autoimmun Rev 2020;19:102572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252120</ArticleId><ArticleId IdType="pubmed">32376393</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilezikian JP, Bikle D, Hewison M, et al. . Mechanisms in endocrinology: vitamin D and COVID-19. Eur J Endocrinol 2020;183:R133–R147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494342</ArticleId><ArticleId IdType="pubmed">32755992</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant WB, Lahore H, Rockwell MS. The benefits of vitamin D supplementation for athletes: better performance and reduced risk of COVID-19. Nutrients 2020;12:3741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7761895</ArticleId><ArticleId IdType="pubmed">33291720</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z, Yan Y, Shu Y, et al. . Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. Nat Commun 2014;5:3594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7091848</ArticleId><ArticleId IdType="pubmed">24800825</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R, Banerjee M, Bhadada SK, et al. . Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis. J Endocrinol Invest 2022;45:53–68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8223190</ArticleId><ArticleId IdType="pubmed">34165766</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaazouee MS, Eleisawy M, Abdalalaziz AM, et al. . Hospital and laboratory outcomes of patients with COVID-19 who received vitamin D supplementation: a systematic review and meta-analysis of randomized controlled trials. Naunyn-Schmiedeberg’s Arch Pharmacol 2023;396:607–620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9743115</ArticleId><ArticleId IdType="pubmed">36508011</ArticleId></ArticleIdList></Reference><Reference><Citation>Argano C, Mallaci Bocchio R, Natoli G, et al. . Protective effect of vitamin D supplementation on COVID-19-related intensive care hospitalization and mortality: definitive evidence from meta-analysis and trial sequential analysis. Pharmaceuticals (Basel, Switzerland) 2023;16:130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9864223</ArticleId><ArticleId IdType="pubmed">36678627</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Ecclesiis O, Gavioli C, Martinoli C, et al. . Vitamin D and SARS-CoV2 infection, severity and mortality: a systematic review and meta-analysis. PLoS ONE 2022;17:e0268396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9258852</ArticleId><ArticleId IdType="pubmed">35793346</ArticleId></ArticleIdList></Reference><Reference><Citation>Bringhurst FR, Demay MB, Kronenberg HM, et al. . Mineral Metabolism. Williams Textbook of Endocrinology 1, 14th ed. Elsevier ‐ Health Sciences Division; 2020;1211‐ 1217.</Citation></Reference><Reference><Citation>Fraser JD, Price PA. Induction of matrix Gla protein synthesis during prolonged 1,25-dihydroxyvitamin D3 treatment of osteosarcoma cells. Calcif Tissue Int 1990;46:270–279.</Citation><ArticleIdList><ArticleId IdType="pubmed">2108798</ArticleId></ArticleIdList></Reference><Reference><Citation>van Ballegooijen AJ, Beulens JWJ, Kieneker LM, et al. . Combined low vitamin D and K status amplifies mortality risk: a prospective study. Eur J Nutr 2021;60:1645–1654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7987611</ArticleId><ArticleId IdType="pubmed">32808059</ArticleId></ArticleIdList></Reference><Reference><Citation>Linneberg A, Kampmann FB, Israelsen SB, et al. . The association of low vitamin K status with mortality in a cohort of 138 hospitalized patients with COVID-19. Nutrients 2021;13:1985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8229962</ArticleId><ArticleId IdType="pubmed">34207745</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AP, Dirajlal-Fargo S, Durieux JC, et al. . “Vitamin K &amp; D deficiencies are independently associated with COVID-19 disease severity. Open Forum Infect Dis 2021;8:ofab408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8344499</ArticleId><ArticleId IdType="pubmed">34642636</ArticleId></ArticleIdList></Reference><Reference><Citation>Dofferhoff ASM, Piscaer I, Schurgers LJ, et al. . Reduced vitamin K status as a potentially modifiable risk factor of severe Coronavirus Disease 2019. Clin Infect Dis 2021;73:e4039–e4046.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499546</ArticleId><ArticleId IdType="pubmed">32852539</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>